Antimicrobial Therapy for Bloodstream Infection Due to Methicillin-Susceptible Staphylococcus aureus in an Era of Increasing Methicillin Resistance: Opportunities for Antimicrobial Stewardship
Restricted accessLetterFirst published online June, 2012
Antimicrobial Therapy for Bloodstream Infection Due to Methicillin-Susceptible Staphylococcus aureus in an Era of Increasing Methicillin Resistance: Opportunities for Antimicrobial Stewardship
ChangFYPeacockJEJrMusherDM. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore)2003; 82: 333–9.
2.
StryjewskiMESzczechLABenjaminDKJr. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis2007; 44: 190–6.
3.
KimSHKimKHKimHB. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother2008; 52: 192–7.
4.
JenkinsTCPriceCSSabelALMehlerPSBurmanWJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis2008; 46: 1000–8.
5.
SchweizerMLFurunoJPHarrisAD. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis2011; 11: 279.
